Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The New Economy and its Winners -- Ignore unavailable to you. Want to Upgrade?

To: Bill Harmond who wrote (50288)	7/1/2009 11:36:17 PM
From: Bill Harmond	Respond to of 57684

17:20 ILMN Illumina guidance conf call summary (38.14 -0.80) -Update- Co noted that, last quarter, it expected the growth rate of its microarray business to moderate over the next two quarters, but what the co actually saw in Q2 was a sequential revenue decline. The primary reason for this slowdown is customers waiting for new array content containing rare variants derived from the Genomes Project. These arrays will support the next round of rich Genome Wide Association studies. Additionally, the co says for the first time it saw the impact of reduced foundation funding in a few key accounts... Pricing in the array market was stable and its competitive position was unchanged in the quarter. Co reaffirmed that the stimulus program under the American Recovery and Reinvestment Act is having a negative short-term impact on both its array and sequencing businesses. Co says that many of its customers have been actively writing grants during the first two quarters, and in selected cases the program has caused order delays as customers wait to learn whether, and to what extent, they will receive stimulus funding. In Q2, the co saw the impact of these stimulus delays to some extent in its array business, but to a greater extent in sequencing. For the first half of the year, the co believes that stimulus has reduced its total revenue by ~ $10-15 mln. ILMN's sequencing business once again saw significant sequential growth in Q2 and exceeded its plan, but not by a sufficient margin to offset the decline in arrays... Co says while it expects the stimulus to have significant positive impact on its business in Q4 and through 2010, it is impacting its ability to forecast its business in the near term. In particular, the government's fiscal year ends this September 30, which the co believes will be a key date for allocation in the first round of stimulus orders. ILMN's fiscal Q3 ends on September 27. The degree to which stimulus orders are backend loaded and the degree to which some groups hold orders waiting for stimulus news could cause substantial variance in its Q3 results. Consequently, co says you should expect it to provide a wider range of quarterly guidance for Q3 than it had provided historically. (Stock is trading ~18% lower after hours at $31.22).

To: Bill Harmond who wrote (50288)	7/2/2009 12:26:03 AM
From: Doren	Respond to of 57684

I agree solar doesn't compete with oil. Not directly but psychologically the stock price tracks oil. All the solars peaked when oil/gas prices peaked.

To: Bill Harmond who wrote (50288)	7/3/2009 11:46:07 AM
From: Lizzie Tudor	Read Replies (1) \| Respond to of 57684

I went to a santa clara county solar program preso about a week ago. One program they are starting up here is if you install solar, which can include all setup even a new roof, they will finance the costs into your property taxes. I think this is one of the Obama green plans. The panels have to be US made from US companies. That excludes almost every solar maker except FLSR and SPWR. I don't think the govt is going to allow cheap dumping of solar panels here by Chinese makers.